Literature DB >> 18043691

Development of CYP2D6 and CYP3A4 in the first year of life.

T N Johnson, G T Tucker, A Rostami-Hodjegan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18043691     DOI： 10.1038/sj.clpt.6100327

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  20 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

2.  Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.

Authors:  Hanna Nylén; Sofia Sergel; Lisa Forsberg; Synnöve Lindemalm; Leif Bertilsson; Katarina Wide; Ulf Diczfalusy
Journal:  Eur J Clin Pharmacol       Date:  2011-01-19       Impact factor: 2.953

3.  Predicted metabolic drug clearance with increasing adult age.

Authors:  Thomas M Polasek; Farhaan Patel; Berit P Jensen; Michael J Sorich; Michael D Wiese; Matthew P Doogue
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

4.  Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model.

Authors:  Khaled Abduljalil; Masoud Jamei; Amin Rostami-Hodjegan; Trevor N Johnson
Journal:  AAPS J       Date:  2014-04-04       Impact factor: 4.009

5.  Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.

Authors:  Chadi Albert Calarge; Del D Miller
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-12       Impact factor: 2.576

6.  Urinary metabolites after intravenous propofol bolus in neonates.

Authors:  Anne Smits; Rene Verbesselt; Aida Kulo; Gunnar Naulaers; Jan de Hoon; Karel Allegaert
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-11-17       Impact factor: 2.441

7.  Challenges in conducting clinical trials in children: approaches for improving performance.

Authors:  Steven E Kern
Journal:  Expert Rev Clin Pharmacol       Date:  2009-11-01       Impact factor: 5.045

8.  Population PK modelling and simulation based on fluoxetine and norfluoxetine concentrations in milk: a milk concentration-based prediction model.

Authors:  Reo Tanoshima; Facundo Garcia Bournissen; Yusuke Tanigawara; Judith H Kristensen; Anna Taddio; Kenneth F Ilett; Evan J Begg; Izhar Wallach; Shinya Ito
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

Review 9.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

10.  Ontogeny of midazolam glucuronidation in preterm infants.

Authors:  Saskia N de Wildt; Greg L Kearns; Darryl J Murry; Gideon Koren; John N van den Anker
Journal:  Eur J Clin Pharmacol       Date:  2009-10-17       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.